| Thomas R Potts, CRNA | |
|
2100 Highway 61 N, Vicksburg, MS 39183-8211 | |
| (601) 883-5000 | |
| (601) 883-5196 |
| Full Name | Thomas R Potts |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 18 Years |
| Location | 2100 Highway 61 N, Vicksburg, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841417656 | NPI | - | NPPES |
| P00675194 | Other | RAIL ROAD MEDICARE | |
| 00639559 | Medicaid | MS | |
| 1358886 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R865054 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mississippi Baptist Medical Center | Jackson, MS | Hospital |
| Baptist Memorial Hospital North Ms | Oxford, MS | Hospital |
| Crossgates River Oaks Hospital | Brandon, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lifelinc Anesthesia Pllc | 0941347447 | 144 |
| Perioperative Services Of Mississippi, Llc | 8921365255 | 93 |
News Archive
Protein Kinase C (PKC) is a family of enzymes that controls the activity of other proteins in a cell by attaching chemical tags. That simple act helps determine cell survival or death.
A team of scientists at the University of Louisville, UCLA and the California Institute of Technology has achieved a significant breakthrough in its initial work with a paralyzed male volunteer at Louisville's Frazier Rehab Institute - the result of 30 years of research to find potential clinical therapies for paralysis.
Scientists at the National Cancer Institute (NCI), have created a model that predicts the survival of follicular lymphoma patients based on the molecular characteristics of their tumors at diagnosis.
Cell Medica, a leading UK cellular therapeutics company that develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, announces today that the first patient has been treated in the CMV~ACE/ASPECT trial at University College Hospital London.
› Verified 7 days ago
| Entity Name | Jackson Anesthesia Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780737577 PECOS PAC ID: 3870585904 Enrollment ID: O20040331000285 |
News Archive
Protein Kinase C (PKC) is a family of enzymes that controls the activity of other proteins in a cell by attaching chemical tags. That simple act helps determine cell survival or death.
A team of scientists at the University of Louisville, UCLA and the California Institute of Technology has achieved a significant breakthrough in its initial work with a paralyzed male volunteer at Louisville's Frazier Rehab Institute - the result of 30 years of research to find potential clinical therapies for paralysis.
Scientists at the National Cancer Institute (NCI), have created a model that predicts the survival of follicular lymphoma patients based on the molecular characteristics of their tumors at diagnosis.
Cell Medica, a leading UK cellular therapeutics company that develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, announces today that the first patient has been treated in the CMV~ACE/ASPECT trial at University College Hospital London.
› Verified 7 days ago
| Entity Name | Anesthesia Consultants Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750300836 PECOS PAC ID: 4486637881 Enrollment ID: O20040608000711 |
News Archive
Protein Kinase C (PKC) is a family of enzymes that controls the activity of other proteins in a cell by attaching chemical tags. That simple act helps determine cell survival or death.
A team of scientists at the University of Louisville, UCLA and the California Institute of Technology has achieved a significant breakthrough in its initial work with a paralyzed male volunteer at Louisville's Frazier Rehab Institute - the result of 30 years of research to find potential clinical therapies for paralysis.
Scientists at the National Cancer Institute (NCI), have created a model that predicts the survival of follicular lymphoma patients based on the molecular characteristics of their tumors at diagnosis.
Cell Medica, a leading UK cellular therapeutics company that develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, announces today that the first patient has been treated in the CMV~ACE/ASPECT trial at University College Hospital London.
› Verified 7 days ago
| Entity Name | Lifelinc Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801021464 PECOS PAC ID: 0941347447 Enrollment ID: O20130522000277 |
News Archive
Protein Kinase C (PKC) is a family of enzymes that controls the activity of other proteins in a cell by attaching chemical tags. That simple act helps determine cell survival or death.
A team of scientists at the University of Louisville, UCLA and the California Institute of Technology has achieved a significant breakthrough in its initial work with a paralyzed male volunteer at Louisville's Frazier Rehab Institute - the result of 30 years of research to find potential clinical therapies for paralysis.
Scientists at the National Cancer Institute (NCI), have created a model that predicts the survival of follicular lymphoma patients based on the molecular characteristics of their tumors at diagnosis.
Cell Medica, a leading UK cellular therapeutics company that develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, announces today that the first patient has been treated in the CMV~ACE/ASPECT trial at University College Hospital London.
› Verified 7 days ago
| Entity Name | Perioperative Services Of Mississippi, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881123123 PECOS PAC ID: 8921365255 Enrollment ID: O20171122000010 |
News Archive
Protein Kinase C (PKC) is a family of enzymes that controls the activity of other proteins in a cell by attaching chemical tags. That simple act helps determine cell survival or death.
A team of scientists at the University of Louisville, UCLA and the California Institute of Technology has achieved a significant breakthrough in its initial work with a paralyzed male volunteer at Louisville's Frazier Rehab Institute - the result of 30 years of research to find potential clinical therapies for paralysis.
Scientists at the National Cancer Institute (NCI), have created a model that predicts the survival of follicular lymphoma patients based on the molecular characteristics of their tumors at diagnosis.
Cell Medica, a leading UK cellular therapeutics company that develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, announces today that the first patient has been treated in the CMV~ACE/ASPECT trial at University College Hospital London.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas R Potts, CRNA 2100 Highway 61 N, Vicksburg, MS 39183-8211 Ph: (601) 883-5000 | Thomas R Potts, CRNA 2100 Highway 61 N, Vicksburg, MS 39183-8211 Ph: (601) 883-5000 |
News Archive
Protein Kinase C (PKC) is a family of enzymes that controls the activity of other proteins in a cell by attaching chemical tags. That simple act helps determine cell survival or death.
A team of scientists at the University of Louisville, UCLA and the California Institute of Technology has achieved a significant breakthrough in its initial work with a paralyzed male volunteer at Louisville's Frazier Rehab Institute - the result of 30 years of research to find potential clinical therapies for paralysis.
Scientists at the National Cancer Institute (NCI), have created a model that predicts the survival of follicular lymphoma patients based on the molecular characteristics of their tumors at diagnosis.
Cell Medica, a leading UK cellular therapeutics company that develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, announces today that the first patient has been treated in the CMV~ACE/ASPECT trial at University College Hospital London.
› Verified 7 days ago
Mr. Michael J Mcreynolds, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2100 Highway 61 N, Vicksburg, MS 39183 Phone: 601-831-1146 | |
Richard M Stone Jr., CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2100 Highway 61 N, Vicksburg, MS 39183 Phone: 601-883-5000 | |
Christopher Sumrall, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2100 Highway 61 N, Vicksburg, MS 39183 Phone: 601-218-6136 | |
Melanie Joan Waldrop, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2100 Hwy 61n, River Region Medical Center, Vicksburg, MS 39183 Phone: 601-883-5000 | |
Mr. Channon Lee Pruitt, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2100 Highway 61 N, Vicksburg, MS 39183 Phone: 601-883-5000 | |
Mr. Michael Edward Killen, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2100 Highway 61 N, Vicksburg, MS 39183 Phone: 601-883-5707 | |
Jackie L Benson, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2100 Highway 61 N, Vicksburg, MS 39183 Phone: 601-883-5000 |